Evaluation and Management of the Asymptomatic Child with Wolff–Parkinson–White
Tóm tắt
Wolff–Parkinson–White (WPW) describes an accessory pathway (AP) that connects the atria and ventricles and allows preexcitation of the ventricle, manifested on the electrocardiogram (ECG) as a short PR interval and a delta wave. WPW syndrome describes the abnormal ECG pattern in patients with associated clinical cardiovascular symptoms, whereas “isolated ventricular preexcitation,” “asymptomatic WPW,” or “asymptomatic WPW syndrome” all refer to the abnormal ECG pattern without associated clinical cardiovascular symptoms. The clinical presentation of symptomatic WPW in young patients with structurally normal hearts can vary based on age and accessory pathway properties. Unfortunately, sudden cardiac death (SCD) can be the first manifestation in patients with WPW. Non-invasive modalities (ECG, ambulatory monitoring, and exercise testing) are used to risk stratify patients. A more invasive test (electrophysiology study) can then be used to identify high-risk pathways. Finally, radiofrequency and/or cryoablation are used to eliminate the accessory pathway and eliminate the risk of arrhythmia and SCD.
Tài liệu tham khảo
Wolff L, Parkinson J, White PD. Bundle-branch block with short P-R interval in healthy young people prone to paroxysmal tachycardia. Am Heart J. 1930;5:685–704.
•• Cohen MI, Triedman JK, Cannon BC, Davis AM, Drago F, Janousek J, et al. PACE/HRS Expert Consensus statement on the management of the asymptomatic young patient with a Wolff–Parkinson–White (WPW, pre-excitation) electrocardiographic pattern. Heart Rhythm. 2012; 9:1007–24. A recent, important consensus statement discussing the evaluation and management of the asymptomatic patient with WPW.
Timmermans C, Smeets JL, Rodriguez LM, Vrouchos G, van den Dool A, Wellens HJ. Aborted sudden death in Wolff–Parkinson–White Syndrome. Am J Cardiol. 1995;76:492–4.
Josephson ME. Preexcitation syndromes. Clinical cardiac electrophysiology. Philadelphia: Lea & Febiger; 1993. p. 311.
Kuck KH, Brugada P, Wellens HJ. Observations on the antidromic type of circus movement tachycardia in the Wolff–Parkinson–White syndrome. J Am Coll Cardiol. 1983;2:1003.
Klein GJ, Bashore TM, Sellers TD, Pritchett EL, Smith WM, Gallagher JJ. Ventricular fibrillation in Wolff–Parkinson–White syndrome. N Engl J Med. 1979;301:1080–5.
Hiss RG, Lamb LE. Electrocardiographic findings in 122,043 individuals. Circulation. 1962;25:947–61.
Swiderski J, Lees MH, Nadas AS. The Wolff–Parkinson–White syndrome in infancy and childhood. Br Heart J. 1962;24:561–80.
Vidaillet HJ Jr, Pressley JC, Henke E, Harrell FE Jr, German LD. Familial occurrence of accessory atrioventricular pathways (preexcitation syndrome). N Engl J Med. 1987;317:65–9.
Munger TM, Packer DL, Hammill SC, Feldman BJ, Bailey KR, Ballard DJ, Holmes DR, Gersh BJ. A population study of the natural history of Wolff–Parkinson–White Syndrome in Olmstead County, Minnesota, 1953–1989. Circulation. 1993;87:866–73.
Deal BJ, Keane JF, Gillette PC, Garson A Jr. Wolff–Parkinson–White syndrome and supraventricular tachycardia during infancy: management and follow-up. J Am Coll Cardiol. 1985;5:130–5.
• Cain N, Irving M, Webber S, Beerman L, Arora G. Natural history of Wolff–Parkinson–White syndrome diagnosed in childhood. Am J Cardiol. 2013;112:961–5. A recent, large study of a pediatric population highlighting the presentation and evolution of symptomatic and asymptomatic WPW patients.
Pappone C, Santinelli V, Rosanio S, Vicedomini G, Nardi S, Pappone A, Tortoriello V, Manguso F, Mazzone P, Gulletta S, Oreto G, Alfieri O. Usefulness of invasive electrophysiologic testing to stratify risk of arrhythmic events in asymptomatic patients with Wolff–Parkinson–White pattern: results from a large prospective long-term follow-up study. J Am Coll Cardiol. 2003;41:239–44.
Russell MW, Dick MD. Incidence of catastrophic events associated with Wolff–Parkinson–White syndrome in young patients: diagnostic and therapeutic dilemma. Circulation. 1993:484(a).
•• Etheridge SP, et al. AB 19-05 life threatening event risk in children with Wolff–Parkinson–White syndrome: a multicenter study. Heart Rhythm. 2016:12;5. An important publication highlighting the high rate of LTEs.
• Mah DY, Sherwin ED, Alexander ME, Cecchin F, Abrams DJ, Walsh EP, Triedman JK. The electrophysiological characteristics of accessory pathways in pediatric patients with intermittent preexcitation. Electrophysiology. 2013;36:1117–22. An important publication regarding the conduction characteristics of accessory pathways in intermittent preexcitation.
Pappone C, Manguso F, Santinelli R, Vicedomini G, Sala S, Paglino G, Mazzone P, Lang CC, Gulletta S, Augello G, Santinelli O, Santinelli V. Radiofrequency ablation in children with asymptomatic Wolff–Parkinson–White syndrome. N Engl J Med. 2004;351:1197–205.
Weng KP, Wolff GS, Young ML. Multiple accessory pathways in pediatric patients with Wolff–Parkinson–White syndrome. Am J Cardiol. 2003;91:1178–83.
Santinelli V, Radinovic A, Manguso F, Vicedomini G, Gulletta S, Paglino G, Mazzone P, Ciconte G, Sacchi S, Sala S, Pappone C. The natural history of asymptomatic ventricular pre-excitation. J Am Coll Cardiol. 2009;53:275–80.
Bricker JT, Porter CJ, Garson A Jr, Gillette PC, McVey P, Traweek M, McNamara DG. Exercise testing in children with Wolff–Parkinson–White syndrome. Am J Cardiol. 1985;55:1001–4.
Daubert C, Ollitrault J, Descaves C, Mabo P, Ritter P, Gouffault J. Failure of the exercise test to predict the anterograde refractory period of the accessory pathway in Wolff Parkinson White syndrome. Pacing Clin Electrophysiol. 1988;11:1130–8.
Perry JC. Giuffre Rm, Garson A Jr, Clues to the electrocardiographic diagnosis of subtle Wolff–Parkinson–White syndrome in children. J Pediatr. 1990;117:871–5.
• Spar DS, Silver ES, Hordof AJ, Liberman L. Relation of the utility of exercise testing for risk assessment in pediatric patients with ventricular preexcitation to pathway location. Am J Cardiol. 2012;109:1011–4. A recent study demonstrating similar conduction characteristics with gradual loss of preexcitation and persistent preexcitation, highlighting that gradual loss of preexcitation has an unclear risk of rapid conduction.
Sarrubi B, Scognamiglio G, Limongelli G, Mercurio B, Pacileo G, Pisacane C, Russo MG, Calabro R. Asymptomatic ventricular pre-excitation in children and adolescents: a 15 year follow up study. Heart. 2003;89:215–7.
Campbell RM, Strieper MJ, Frias PA, Collins KK, Van Hare GF, Dubin AM. Survey of current practice of pediatric electrophysiologists for asymptomatic Wolff–Parkinson–White syndrome. Pediatrics. 2003;111:e245–7.
Kugler JD, Danford DA, Houston KA, Felix G. Pediatric radiofrequency catheter ablation registry success, fluoroscopy time, and complication rate for supraventricular tachycardia: comparison of early and recent eras. J Cardiovasc Electrophysiol. 2002;13:336–41.
Van Hare GF, Javitz H, Carmell D, Saul JP, Tanel RE, Fischbach PS, Kanter RJ, Schaffer M, Dunnigan A, Colan S, Serwer G. Prospective assessment after pediatric cardiac ablation: demographics, medical profiles and initial outcomes. J Cardiovasc Electrophysiol. 2004;15:759–70.
•• Ceresnak SR, Dubin AM, Kim JJ, Valdes SO, Fishberger SB, Shetty I, Zimmerman F, Tanel RE, Epstein MR, Motonaga KS, Capone CA, Nappo L, Gates GJ, Pass RH. Success rates in pediatric WPW ablation are improved with 3-dimensional mapping systems compared with fluoroscopy alone: a multicenter study. J Cardiovasc Electrophysiol. 2015;26:412–6. An important publication regarding the success of 3D mapping and decreased fluoroscopy time during ablations.
Gaita F, Montefusco A, Riccardi R, Scaglione M, Grossi S, Caponi D, Caruzzo E, Giustetto C, Bocchiardo M, Di Donna P. Acute and long-term outcome of transvenous cryothermal catheter ablation of supraventricular arrhythmias involving the perinodal region. J Cardiovasc Med. 2006;7:785–92.
Nagaraju L, Dipika M, Aziz PF. Use of 3D electro-anatomical navigation (CARTO-3) to minimize or eliminate fluoroscopy use in the ablation of pediatric supraventricular tachyarrhythmias. Pacing Clin Electrophysiol. 2016;. doi:10.1111/pace.12830.